Amgen loses as top U.S. court backs class actions
(Reuters) - The U.S. Supreme Court made it easier on Wednesday for shareholders to bring class-action lawsuits, breaking a recent line of decisions that had made it harder to sue corporate defendants collectively and perhaps obtain greater recoveries.
For full story visit Reuters.
The full decision is available at the US Supreme Court's website.
Read More Firm News
- Robbins Geller Partners Aelish Baig and Jessica Shinnefield Recognized as “Born Leaders” and Plaintiffs’ Lawyers Trailblazers by The National Law JournalMay 4, 2021
- Robbins Geller Secures Appellate Win After Supreme Court of New York Appellate Division Affirms Denial of Motion to Dismiss in Securities Class Action Against Alnylam Pharmaceuticals, Inc.April 30, 2021
- April 29, 2021
- April 22, 2021
- April 21, 2021